HIV-1 reverse transcriptase (RT) polymorphism 172K suppresses the effect of clinically relevant drug resistance mutations to both nucleoside and non-nucleoside RT inhibitors

导出原文传递

翻译打印收藏纠错

作者： Hachiya,A. ^[1] ; Marchand,B. ^[2] ; Kirby,K.A. ^[3] ; Michailidis,E. ^[4] ; Tu,X. ; Palczewski,K. ; Ong,Y.T. ; Li,Z. ; Griffin,D.T. ; Schuckmann,M.M. ; Tanuma,J. ; Oka,S. ; Singh,K. ; Kodama,E.N. ; Sarafianos,S.G.

作者单位： Case Western University, Cleveland, OH 44106, United States ^[1] AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo 162-8655, Japan ^[2] Division of Emerging Infectious Diseases, Tohoku University School of Medicine, Sendai 980-8575 ^[3] Christopher S. Bond Life Sciences Center, Department of Molecular Microbiology and Immunology ^[4]

发布时间 2014-01-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Journal of biological chemistry

2012年287卷35期

29988-29999页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

HIV-1 reverse transcriptase (RT) polymorphism 172K suppresses the effect of clinically relevant drug resistance mutations to both nucleoside and non-nucleoside RT inhibitors

The Journal of biological chemistry

相似文献

The Journal of biological chemistry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

HIV-1 reverse transcriptase (RT) polymorphism 172K suppresses the effect of clinically relevant drug resistance mutations to both nucleoside and non-nucleoside RT inhibitors

The Journal of biological chemistry

相似文献

The Journal of biological chemistry

相关期刊

检索历史清除